Anthony Frank Magliulo, MD | |
642 Ulukahiki St, Ste 303, Kailua, HI 96734-4439 | |
(808) 262-0606 | |
(808) 262-1889 |
Full Name | Anthony Frank Magliulo |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 43 Years |
Location | 642 Ulukahiki St, Kailua, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558471342 | NPI | - | NPPES |
MD500902 | Other | HI | MDX |
0000BDPDZ | Other | KAISER ADDED CHOICE | |
00E002313-4 | Other | HI | BLUE CARD HAWAII |
00E002313-4 | Other | HI | QUEST HMSA |
020921 | Medicaid | HI | |
99-0280579 | Other | OTHER COMMERCIAL | |
00E002313-4 | Other | HI | HMSA |
00E002313-4 | Other | FEP | |
02092101 | Other | HI | QUEST ALOHA CARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 5009 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bayada Home Health Care | Honolulu, HI | Home health agency |
Adventist Health Castle | Kailua, HI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Castle Medical Center | 6608762778 | 71 |
News Archive
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
The (New Orleans) Times-Picayune: Louisiana "Gov. Bobby Jindal will present his 2010-11 budget request Friday, which is expected to call for cuts to health care, education and other areas of state government as his administration outlines plans for plugging a $1 billion shortfall. ... The general-fund growth is not nearly enough to offset a loss of about $650 million in federal health-care financing, the rising cost of state pensions, automatic pay raises for state workers and inflation in health-care programs."
AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
› Verified 6 days ago
Entity Name | Castle Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316937691 PECOS PAC ID: 6608762778 Enrollment ID: O20040225000693 |
News Archive
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
The (New Orleans) Times-Picayune: Louisiana "Gov. Bobby Jindal will present his 2010-11 budget request Friday, which is expected to call for cuts to health care, education and other areas of state government as his administration outlines plans for plugging a $1 billion shortfall. ... The general-fund growth is not nearly enough to offset a loss of about $650 million in federal health-care financing, the rising cost of state pensions, automatic pay raises for state workers and inflation in health-care programs."
AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
› Verified 6 days ago
Entity Name | Ekahi Wellness, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376031013 PECOS PAC ID: 1850647876 Enrollment ID: O20180705002258 |
News Archive
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
The (New Orleans) Times-Picayune: Louisiana "Gov. Bobby Jindal will present his 2010-11 budget request Friday, which is expected to call for cuts to health care, education and other areas of state government as his administration outlines plans for plugging a $1 billion shortfall. ... The general-fund growth is not nearly enough to offset a loss of about $650 million in federal health-care financing, the rising cost of state pensions, automatic pay raises for state workers and inflation in health-care programs."
AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Anthony Frank Magliulo, MD 642 Ulukahiki St, Ste 303, Kailua, HI 96734-4439 Ph: (808) 262-0606 | Anthony Frank Magliulo, MD 642 Ulukahiki St, Ste 303, Kailua, HI 96734-4439 Ph: (808) 262-0606 |
News Archive
A recent study, conducted at the Gerontology Research Center of the University of Jyväskylä, shows that walk-friendly environmental design may provide opportunities for physical activity in old age.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
The (New Orleans) Times-Picayune: Louisiana "Gov. Bobby Jindal will present his 2010-11 budget request Friday, which is expected to call for cuts to health care, education and other areas of state government as his administration outlines plans for plugging a $1 billion shortfall. ... The general-fund growth is not nearly enough to offset a loss of about $650 million in federal health-care financing, the rising cost of state pensions, automatic pay raises for state workers and inflation in health-care programs."
AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23, 2009 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.
› Verified 6 days ago
Dr. Sylvia Wang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 414 Uluniu St, Kailua, HI 96734 Phone: 808-261-8345 Fax: 808-262-5239 | |
Mr. Howard I Keller, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Aulike St, Suite 601, Kailua, HI 96734 Phone: 808-262-6951 Fax: 808-261-7856 | |
Dr. Jamalah Adeeba Munir, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Kailua, HI 96734 Phone: 808-263-5174 | |
Naoky C Tsai, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Ulukahiki St, Ste 103, Kailua, HI 96734 Phone: 808-263-5174 Fax: 808-266-3614 | |
Dr. Joseph A Palma, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 638 Papalani St, Kailua, HI 96734 Phone: 808-262-9887 Fax: 808-262-7013 | |
Ramy A Badawi, MD, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 808-793-7747 Fax: 808-625-4808 | |
Dr. Helen Ing, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 642 Ulukahiki St, #211, Kailua, HI 96734 Phone: 808-261-0765 Fax: 808-262-5636 |